Novo's obesity drug Wegovy (semaglutide) has become the first GLP-1 obesity treatment in Korea to seek national health ...

ADEL, a Korean biotech developing treatments for neurodegenerative diseases, including Alzheimer's disease, is seeking a ...

Methylphenidate, a controlled drug used to treat attention-deficit/hyperactivity disorder (ADHD), was prescribed to 964 ...

Patient-specific genetic mutation monitoring using digital PCR could help detect changes linked to leukemia relapse after ...

Professor Park Jung-yul of Korea University Anam Hospital has taken office as president of the World Medical Association (WMA ...

Orum Therapeutics, a biotech company specializing in degrader-antibody conjugates (DACs), said Tuesday it had dosed the first ...

AITRICS, a Korean medical AI company, said Wednesday it was named one of TIME's World's Top HealthTech Companies of 2026. The ...

Merck Healthcare Korea announced the appointment of Lee Dong-yeol, former country medical director at Antengene Korea, as ...

Professor Cho Tae-joon of the Department of Pediatric Orthopedics at Seoul National University Hospital (SNUH) has been ...

STCUBE PHARMACEUTICAL said Wednesday it will present three studies on its investigational BTN1A1-targeting immunotherapy nelmastobart at the European Society for Medical Oncology (ESMO) Congress 2026, ...

Daewoong Pharmaceutical is preparing to manufacture its experimental semaglutide microneedle patch, which entered clinical ...

VAIM launched its medical aesthetics product JuveLook in China on Tuesday, holding an event in Beijing with local partner Bloomage Biotech attended by about 500 physicians, hospital executives and oth ...